Sidebar: North Carolina's Process for Developing Our COVID-19 Vaccine Plan

N C Med J. 2021 Mar-Apr;82(2):127-128. doi: 10.18043/ncm.82.2.127.

Authors

Amanda Fuller Moore¹, Elizabeth Cuervo Tilson², Charlene A Wong³

Affiliations

¹ Pharmacist, Epidemiology Section, North Carolina Division of Public Health, North Carolina Department of Health and Human Services, Raleigh, North Carolina. Amanda.fullermoore@dhhs.nc.gov.
² State health director/chief medical officer, North Carolina Department of Health and Human Services, Raleigh, North Carolina.
³ Chief health policy officer for COVID-19, North Carolina Department of Health and Human Services, Raleigh, North Carolina.

PMID: 33649130
DOI: 10.18043/ncm.82.2.127

No abstract available

MeSH terms

COVID-19 Vaccines*
COVID-19*
Humans
North Carolina
SARS-CoV-2

Substances

COVID-19 Vaccines